Overview

Alterations of Blood Clotting With the Use of Sequential Compression Devices on the Lower Limbs

Status:
Terminated
Trial end date:
2010-11-01
Target enrollment:
Participant gender:
Summary
This study aims to assess possible alteration in coagulation (blood clotting) following treatment with sequential compression devices (SCD) plus low-molecular weight heparin (LMWH) as opposed to LMWH alone. The investigators will examine coagulation in the early postoperative period of patients undergoing major abdominal surgery during their stay in our Intensive Care Unit. In addition to common laboratory tests, the investigators will examine coagulation using TEGĀ®, a device which allows a semi-quantitative examination of all phases of coagulation.
Phase:
N/A
Details
Lead Sponsor:
University of Parma
Treatments:
Anticoagulants
Calcium heparin
Dalteparin
Heparin
Heparin, Low-Molecular-Weight
Tinzaparin